National consumer drug safety network launched.
Priest
Alicia
A
D002170:Canada; D003257:Consumer Product Safety; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D004335:Drug and Narcotic Control; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D013450:Sulfones / Q000009:adverse effects
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib